Top compounds associated with response to MYBL2


Feature Type Standardized
Nominal ANOVA
mRNA momelotinib CTRPv2 pan-cancer AAC 0.037 0.3
mRNA BRD-K94991378 CTRPv2 pan-cancer AAC -0.042 0.3
mRNA BRD-K13999467 CTRPv2 pan-cancer AAC 0.038 0.3
mRNA lovastatin CTRPv2 pan-cancer AAC -0.039 0.3
mRNA I-BET-762 GDSC1000 pan-cancer AAC 0.029 0.3
mRNA Y-39983 GDSC1000 pan-cancer AAC 0.033 0.3
mRNA Ki8751 CTRPv2 pan-cancer AAC -0.038 0.3
mRNA Lisitinib GDSC1000 pan-cancer AAC -0.035 0.3
mRNA Mitomycin-C CTRPv2 pan-cancer AAC 0.034 0.3
mRNA B02 CTRPv2 pan-cancer AAC 0.037 0.3
Download CSV